Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeometals Regulatory News (NMT)

Share Price Information for Neometals (NMT)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £26.93m
NMT Live PriceLast checked at - London Stock Exchange

Intraday Neometals Share Chart

Trading Statement

11 Jul 2005 14:14

NMT Group PLC11 July 2005 NMT Group PLC Trading Update In January 2005 NMT Group PLC ("the Company") signed a letter of intent for themanufacture and distribution of its 2nd Generation retractable safety syringe inthe Far East which provided for a license fee stage payment from the prospectivelicensing partner at the beginning of July 2005, subject to agreement of aformal contract. Although the Company remains in communication with the prospective licensingpartner, to date no formal contract has been signed nor has any stage paymentbeen received. The outcome and timing of this contract is now uncertain andoutside of the Company's control. The Safety Needle Unit is production ready, with the project fully costed andsub-contract manufacturers identified. With regard to the major pharmaceuticalcompany, which had decided to postpone proceeding with a license for themanufacture and distribution of the device following the detailed marketingstudy, discussions are anticipated to resume in autumn 2005, aimed at a 2007launch. Additional discussions on licensing the Safety Needle Unit began in June withtwo US-based companies, one a major pharmaceutical company and the other a majormedical device supplier. Both companies have expressed interest in taking theproduct to the next stage of their internal evaluations. The Company's balance sheet remains strong with cash at 30th June 2005 standingat £6.5million. However, given the difficulty in predicting the outcome of the above licensingdiscussions, the Board now intends to explore all options for maximising thevalue of the Company's assets as rapidly as possible, including the sale of theCompany or the sale of its business operations followed by a sale or mergerstrategy for obtaining the best value for shareholders for the Company's cashassets. The Company will keep shareholders informed of further developments. Enquiries: Contact: Tony FletcherChairmanNMT Group PLC Tel: 01506 445000 Mobile: 07836 725246 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Feb 20257:00 amRNSCancellation - Neometals Ltd
23rd Jan 20257:01 amRNSQuarterly Activities Report
23rd Jan 20257:01 amRNSQuarterly Cashflow
17th Jan 20257:00 amRNSCancellation of Performance Rights
20th Dec 20247:00 amRNSProposed Cancellation of Admission to AIM
6th Dec 20247:00 amRNSDirector/PDMR Dealings
22nd Nov 20249:09 amRNSResult of Annual General Meeting
22nd Nov 20247:42 amRNSChairman’s AGM 2024 Address
18th Nov 20241:14 pmRNS2024 Annual General Meeting Broadcast
12th Nov 20247:00 amRNSPositive Results from ELi™ Pilot Trial
8th Nov 20249:24 amRNSDirector / PDMR Participation in Entitlement Offer
7th Nov 202410:16 amRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSResults of Entitlement Offer
24th Oct 20247:01 amRNSQuarterly Activities Report
24th Oct 20247:01 amRNSQuarterly Cashflow
22nd Oct 20247:00 amRNSMercedes Benz Plant Opening
21st Oct 20247:00 amRNSNotice of Annual General Meeting
21st Oct 20247:00 amRNSEntitlement Offer Opens
18th Oct 20247:00 amRNSDirector/PDMR Dealings
14th Oct 20249:49 amRNSPosting of Annual Report
11th Oct 20247:00 amRNSA$4 Million Placement and Entitlement Offer
9th Oct 20247:00 amRNSASX Trading Halt
30th Sep 20247:50 amRNSResult of EGM
26th Sep 20248:56 amRNSAnnual Financial Report
23rd Sep 20247:00 amRNSBarrambie Gold Exploration Target
20th Sep 20247:00 amRNSAGM Update
16th Sep 20247:00 amRNSVRP receives EU supported capital injection
27th Aug 202410:02 amRNSNotice of EGM
22nd Aug 20247:00 amRNSNeometals Strategy Update
22nd Aug 20247:00 amRNSPrecious Metals Recovery Option Lapse
19th Aug 20247:00 amRNSUS$3M Placement
16th Aug 20247:00 amRNSResults of Extraordinary General Meeting
7th Aug 20247:00 amRNSCorporate Presentation
30th Jul 20247:19 amRNSQuarterly Activities Report
30th Jul 20247:15 amRNSQuarterly Cashflow
17th Jul 20248:36 amRNSNotice of Extraordinary General Meeting
11th Jul 20247:12 amRNSAppointment of Company Secretary
9th Jul 20249:59 amRNSDirector/PDMR Dealings
4th Jul 202411:59 amRNSIssue of Shares
27th Jun 202410:26 amRNSDirector Change
6th Jun 20248:34 amRNSDirector/PDMR Shareholding
4th Jun 20247:00 amRNSPrecious Metals Due Diligence Update
3rd Jun 20247:00 amRNSAppointment of Chief Financial Officer
29th May 20247:00 amRNSNeometals Strengthens its Senior Management Team
28th May 20247:00 amRNSOption to acquire Precious Metals Process & Plant
22nd May 20247:00 amRNSFinal Stage of ELi™ Pilot Trial Commences
15th May 202412:38 pmRNSNeometals Shares Commence Trading on OTCQX market
24th Apr 20247:01 amRNSQuarterly Cashflow Report
24th Apr 20247:00 amRNSQuarterly Activities Report
18th Apr 202410:24 amRNSChange in Substantial Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.